These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38652764)

  • 21. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs.
    Lanza FL
    Scand J Gastroenterol Suppl; 1989; 163():24-31. PubMed ID: 2683026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of commonly used NSAID's on gastric mucosa. A clinico-endoscopic and histopathological study.
    Misra R; Pandey H; Chandra M; Chandra M; Agarwal PK; Pandeya SN
    J Assoc Physicians India; 1990 Dec; 38(12):913-5. PubMed ID: 2096127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups.
    Euler AR; Safdi M; Rao J; Jaszewski R; Welsh J; Le V; Raskin J; Fleischmann R; Razzaque M; Champion C
    Gastroenterology; 1990 Jun; 98(6):1549-57. PubMed ID: 2186951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.
    Konturek JW; Dembinski A; Konturek SJ; Stachura J; Domschke W
    Gastroenterology; 1998 Feb; 114(2):245-55. PubMed ID: 9453483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathogenic mechanism of aspirin-induced gastric ulceration and its characteristics].
    Takeuchi K; Amagase K; Abe N; Kojo A
    Nihon Rinsho; 2010 Nov; 68(11):1962-5. PubMed ID: 21061516
    [No Abstract]   [Full Text] [Related]  

  • 26. Aspirin treatment exacerbates oral infections by Trypanosoma cruzi.
    Cossentini LA; Da Silva RV; Yamada-Ogatta SF; Yamauchi LM; De Almeida Araújo EJ; Pinge-Filho P
    Exp Parasitol; 2016 May; 164():64-70. PubMed ID: 26826555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between transmucosal potential difference and morphological damage during aspirin injury of gastric mucosa in rats.
    Cook GA; Elliott SL; Skeljo MV; Giraud AS; Yeomans ND
    J Gastroenterol Hepatol; 1996 Mar; 11(3):264-9. PubMed ID: 8742924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury.
    Donnelly MT; Goddard AF; Filipowicz B; Morant SV; Shield MJ; Hawkey CJ
    Aliment Pharmacol Ther; 2000 May; 14(5):529-34. PubMed ID: 10792114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the upper gastrointestinal effects of etodolac and aspirin in healthy dogs.
    Nishihara K; Kikuchi H; Kanno T; Tanabe S; Sarashina T; Uzuka Y
    J Vet Med Sci; 2001 Oct; 63(10):1131-3. PubMed ID: 11714031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin-induced mucosal cell death in human gastric cells: role of a caspase-independent mechanism.
    Leung AM; Redlak MJ; Miller TA
    Dig Dis Sci; 2009 Jan; 54(1):28-35. PubMed ID: 18612824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifidobacterium breve Bif195 ameliorates aspirin-induced gastric mucosal damage: A randomised, double blind, placebo-controlled crossover trial.
    Løn N; Engel S; Damholt A; Mortensen B; Haaber AB; Wellejus A; Knop FK
    Aliment Pharmacol Ther; 2024 Feb; 59(3):341-349. PubMed ID: 38036761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of gastroduodenal mucosal injuries in aspirin users.
    Thongbai T
    J Med Assoc Thai; 2013 Nov; 96(11):1423-7. PubMed ID: 24428091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study.
    Chowdhury A; Ganguly G; Chowdhury D; Santra A; Gupta JD; Roy T
    Indian J Gastroenterol; 2001; 20(6):227-9. PubMed ID: 11817775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased gastroduodenal concentrations of transforming growth factor alpha in adaptation to aspirin in monkeys and rats.
    Romano M; Lesch CA; Meise KS; Veljaca M; Sanchez B; Kraus ER; Boland CR; Guglietta A; Coffey RJ
    Gastroenterology; 1996 May; 110(5):1448-55. PubMed ID: 8613050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between endogenous carbon monoxide and hydrogen sulfide in the mechanism of gastroprotection against acute aspirin-induced gastric damage.
    Magierowski M; Magierowska K; Hubalewska-Mazgaj M; Adamski J; Bakalarz D; Sliwowski Z; Pajdo R; Kwiecien S; Brzozowski T
    Pharmacol Res; 2016 Dec; 114():235-250. PubMed ID: 27825819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin.
    Brzozowski T; Konturek P; Konturek SJ; Kwiecień S; Sliwowski Z; Pajdo R; Duda A; Ptak A; Hahn EG
    Int J Colorectal Dis; 2003 Jul; 18(4):320-9. PubMed ID: 12774247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid.
    Komoike Y; Takeeda M; Tanaka A; Kato S; Takeuchi K
    Dig Dis Sci; 2002 Jul; 47(7):1538-45. PubMed ID: 12141814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice.
    Cipriani S; Mencarelli A; Bruno A; Renga B; Distrutti E; Santucci L; Baldelli F; Fiorucci S
    Br J Pharmacol; 2013 Jan; 168(1):225-37. PubMed ID: 22881598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rolipram, a specific type IV phosphodiesterase inhibitor, ameliorates aspirin-induced gastric mucosal injury in rats.
    Odashima M; Otaka M; Jin M; Komatsu K; Konishi N; Wada I; Horikawa Y; Matsuhashi T; Ohba R; Oyake J; Hatakeyama N; Watanabe S
    Dig Dis Sci; 2005 Jun; 50(6):1097-102. PubMed ID: 15986861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.